Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Renal Failure

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    June 2022
  1. THEOFILIS P, Vordoni A, Kalaitzidis RG
    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
    Am J Nephrol. 2022 Jun 29:1-10. doi: 10.1159/000525441.
    PubMed     Abstract available


  2. LEGENDRE B, Lobbedez T, Couchoud C, Lassalle M, et al
    Switch from Hemodialysis to Peritoneal Dialysis: Does the Time Spent on Hemodialysis Impact Outcomes in Peritoneal Dialysis?
    Am J Nephrol. 2022 Jun 22:1-10. doi: 10.1159/000524960.
    PubMed     Abstract available


  3. VRIST MH, Ostergaard AMH, Langaa SS, Mose FH, et al
    Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy.
    Am J Nephrol. 2022 Jun 7:1-13. doi: 10.1159/000524961.
    PubMed     Abstract available


    May 2022
  4. WANG K, Qian D, Hu Y, Cheng Y, et al
    Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States.
    Am J Nephrol. 2022 May 24:1-10. doi: 10.1159/000524382.
    PubMed     Abstract available


  5. BISHOP CW, Strugnell SA, Csomor P, Kaiser E, et al
    Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Am J Nephrol. 2022 May 12:1-9. doi: 10.1159/000524289.
    PubMed     Abstract available


    April 2022
  6. MURRAY AM, Slinin Y, Tupper DE, Pederson SL, et al
    Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study.
    Am J Nephrol. 2022 Apr 28:1-11. doi: 10.1159/000524166.
    PubMed     Abstract available


  7. GOODKIN DA, Zhao J, Cases A, Nangaku M, et al
    Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
    Am J Nephrol. 2022 Apr 22:1-10. doi: 10.1159/000523947.
    PubMed     Abstract available


  8. AGRAWAL D, Varade D, Shah H, Nazar A, et al
    Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523961.
    PubMed     Abstract available


  9. GANG S, Khetan P, Varade D, Chinta VR, et al
    Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523949.
    PubMed     Abstract available


  10. KIM DH, Park HC, Cho A, Kim J, et al
    Nurse Caseload and Patient Survival in Hemodialysis Units: A Korean Nationwide Cohort Study.
    Am J Nephrol. 2022 Apr 20:1-9. doi: 10.1159/000524110.
    PubMed     Abstract available


    March 2022
  11. GOLLIE JM, Patel SS, Harris-Love MO, Cohen SD, et al
    Fatigability and the Role of Neuromuscular Impairments in Chronic Kidney Disease.
    Am J Nephrol. 2022 Mar 28:1-11. doi: 10.1159/000523714.
    PubMed     Abstract available


  12. BLEYER AJ, Westemeyer M, Xie J, Bloom MS, et al
    Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel.
    Am J Nephrol. 2022 Mar 24:1-10. doi: 10.1159/000522226.
    PubMed     Abstract available


  13. SCHREIER DJ, Rule AD, Kashani KB, Mara KC, et al
    Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
    Am J Nephrol. 2022 Mar 16:1-9. doi: 10.1159/000522139.
    PubMed     Abstract available


  14. OKUBO A, Doi T, Morii K, Nishizawa Y, et al
    Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2022 Mar 8:1-7. doi: 10.1159/000522225.
    PubMed     Abstract available


    February 2022
  15. SOOHOO M, Obi Y, Rivara MB, Adams SV, et al
    Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Am J Nephrol. 2022 Feb 28:1-12. doi: 10.1159/000521508.
    PubMed     Abstract available


  16. FUJII N, Hamano T, Hsu JY, Imai E, et al
    A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
    Am J Nephrol. 2022 Feb 28:1-14. doi: 10.1159/000521386.
    PubMed     Abstract available


  17. TSAI HC, Ou SM, Wu CC, Huang CC, et al
    Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 25:1-9. doi: 10.1159/000522049.
    PubMed     Abstract available


  18. ZHANG J, Fuhrer T, Ye H, Kwan B, et al
    High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Am J Nephrol. 2022 Feb 23:1-11. doi: 10.1159/000521940.
    PubMed     Abstract available


  19. SHASHAR M, Nacasch N, Grupper A, Benchetrit S, et al
    Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 16:1-8. doi: 10.1159/000521676.
    PubMed     Abstract available


  20. VARETA G, Georgianos PI, Vaios V, Sgouropoulou V, et al
    Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings.
    Am J Nephrol. 2022 Feb 4:1-9. doi: 10.1159/000521861.
    PubMed     Abstract available


    January 2022
  21. BENMIRA AM, Moranne O, Prelipcean C, Pambrun E, et al
    Direct Determination rather than Oscillometric Estimation of Systolic Blood Pressure in Patients with Severe Chronic Kidney Disease.
    Am J Nephrol. 2022 Jan 12:1-9. doi: 10.1159/000520996.
    PubMed     Abstract available


  22. BHANDARI SK, Zhou H, Shaw SF, Shi J, et al
    Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System.
    Am J Nephrol. 2022 Jan 11:1-9. doi: 10.1159/000520466.
    PubMed     Abstract available


    December 2021
  23. DIAMANTIDIS CJ, Zepel L, Wang V, Smith VA, et al
    Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.
    Am J Nephrol. 2021;52:949-957.
    PubMed     Abstract available


  24. YOU HS, Shin SJ, Kim J, Kang HT, et al
    Statin Use and Incidence of Chronic Kidney Disease in Hypercholesterolemia Patients with Normal Renal Function.
    Am J Nephrol. 2021 Dec 3:1-9. doi: 10.1159/000520532.
    PubMed     Abstract available


    November 2021
  25. OTOBE Y, Yamada M, Hiraki K, Onari S, et al
    Physical Exercise Improves Cognitive Function in Older Adults with Stage 3-4 Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2021 Nov 30:1-11. doi: 10.1159/000520230.
    PubMed     Abstract available


  26. PAIK JM, Zhuo M, York C, Tsacogianis T, et al
    Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.
    Am J Nephrol. 2021 Nov 23:1-10. doi: 10.1159/000520028.
    PubMed     Abstract available


  27. THOMSON BKA, Pilkey NG, Monteith B, Holden RM, et al
    A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve.
    Am J Nephrol. 2021;52.
    PubMed     Abstract available


  28. WEE HN, Liu JJ, Ching J, Kovalik JP, et al
    The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.
    Am J Nephrol. 2021 Nov 9:1-17. doi: 10.1159/000519811.
    PubMed     Abstract available


  29. HU S, Wang D, Ma T, Yuan F, et al
    Association between Preoperative Monocyte-to-Lymphocyte Ratio and Late Arteriovenous Fistula Dysfunction in Hemodialysis Patients: A Cohort Study.
    Am J Nephrol. 2021 Nov 8:1-7. doi: 10.1159/000519822.
    PubMed     Abstract available


    October 2021
  30. JELANI QU, Llanos-Chea F, Bogra P, Trejo-Paredes C, et al
    Guideline-Directed Medical Therapy in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Intervention.
    Am J Nephrol. 2021 Oct 27:1-9. doi: 10.1159/000519484.
    PubMed     Abstract available


  31. GOLDBERG A, Garcia-Arroyo F, Sasai F, Rodriguez-Iturbe B, et al
    Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Am J Nephrol. 2021 Oct 21:1-8. doi: 10.1159/000519491.
    PubMed     Abstract available


  32. SELLIER AB, Seiler-Mussler S, Emrich IE, Bohm M, et al
    FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease.
    Am J Nephrol. 2021 Oct 21:1-9. doi: 10.1159/000519274.
    PubMed     Abstract available


    September 2021
  33. EREZ D, Fanadka F, Benchetrit S, Cohen-Hagai K, et al
    The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients.
    Am J Nephrol. 2021 Sep 17:1-7. doi: 10.1159/000518399.
    PubMed     Abstract available


  34. THEOFILIS P, Vordoni A, Koukoulaki M, Vlachopanos G, et al
    Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives.
    Am J Nephrol. 2021 Sep 17:1-9. doi: 10.1159/000518456.
    PubMed     Abstract available


  35. CIARDULLO S, Ballabeni C, Trevisan R, Perseghin G, et al
    Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease.
    Am J Nephrol. 2021;52:666-672.
    PubMed     Abstract available


  36. ROY N, Rosas SE
    IL-6 Is Associated with Progression of Coronary Artery Calcification and Mortality in Incident Dialysis Patients.
    Am J Nephrol. 2021 Sep 15:1-8. doi: 10.1159/000518652.
    PubMed     Abstract available


  37. COLOMBIJN JMT, Bonenkamp AA, van Eck van der Sluijs A, Bijlsma JA, et al
    Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients.
    Am J Nephrol. 2021 Sep 10:1-10. doi: 10.1159/000518454.
    PubMed     Abstract available


  38. LIU W, Wang L, Li X, Gao C, et al
    C-X-C Motif Chemokine Ligand 16 Is a Potent Predictor of Outcomes in Dialysis Patients.
    Am J Nephrol. 2021 Sep 10:1-10. doi: 10.1159/000518400.
    PubMed     Abstract available


  39. CHALKIA A, Gakiopoulou H, Theohari I, Foukas PG, et al
    Transforming Growth Factor-beta1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease.
    Am J Nephrol. 2021 Sep 8:1-13. doi: 10.1159/000517619.
    PubMed     Abstract available


    July 2021
  40. PERGOLA PE, Belo D, Crawford P, Moustafa M, et al
    Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
    Am J Nephrol. 2021 Jul 22:1-10. doi: 10.1159/000516012.
    PubMed     Abstract available


  41. DASHPUTRE AA, Sumida K, Thomas F, Gatwood J, et al
    Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.
    Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902.
    PubMed     Abstract available


    June 2021
  42. LIN Z, Liu L, Zhang R, Lin X, et al
    Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
    Am J Nephrol. 2021 Jun 16:1-12. doi: 10.1159/000516187.
    PubMed     Abstract available


  43. CHOI YS, Lee HS, Joo N, Park P, et al
    Efficacy and Safety of Plastic Cannulae Compared with Metal Needles in the Initial Use of an Arteriovenous Fistulae in Incident Hemodialysis Patients: A Randomized Controlled Study.
    Am J Nephrol. 2021 Jun 10:1-8. doi: 10.1159/000516212.
    PubMed     Abstract available


  44. SHIGEMATSU T, Une Y, Ikejiri K, Kanda H, et al
    Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.
    Am J Nephrol. 2021 Jun 7:1-11. doi: 10.1159/000516156.
    PubMed     Abstract available


    May 2021
  45. BANERJEE T, Carrero JJ, McCulloch C, Burrows NR, et al
    Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption.
    Am J Nephrol. 2021 May 27:1-12. doi: 10.1159/000514754.
    PubMed     Abstract available


  46. VODOSEK HOJS N, Ekart R, Bevc S, Piko N, et al
    CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients.
    Am J Nephrol. 2021 May 11:1-8. doi: 10.1159/000516121.
    PubMed     Abstract available


  47. OZCAN C
    Conduction Intervals and Atrial Fibrillation in Chronic Kidney Disease.
    Am J Nephrol. 2021 May 10:1-2. doi: 10.1159/000516153.
    PubMed    


  48. SUBRAMANIAN N, Han J, Leeper NJ, Ross EG, et al
    Comparison of Pre-Amputation Evaluation in Patients with and without Chronic Kidney Disease.
    Am J Nephrol. 2021 May 6:1-8. doi: 10.1159/000516017.
    PubMed     Abstract available


  49. LEE HJ, Kwak N, Kim YC, Choi SM, et al
    Impact of Sleep Duration on Mortality and Quality of Life in Chronic Kidney Disease: Results from the 2007-2015 KNHANES.
    Am J Nephrol. 2021 May 6:1-8. doi: 10.1159/000516096.
    PubMed     Abstract available


  50. SCOVNER KM, Correa S, Claggett BL, Barrett CD, et al
    Specific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease.
    Am J Nephrol. 2021 May 5:1-8. doi: 10.1159/000515670.
    PubMed     Abstract available


    April 2021
  51. BOYER A, Lanot A, Lambie M, Verger C, et al
    Trends in Peritoneal Dialysis Technique Survival, Death, and Transfer to Hemodialysis: A Decade of Data from the RDPLF.
    Am J Nephrol. 2021 Apr 27:1-10. doi: 10.1159/000515472.
    PubMed     Abstract available


  52. MURASHIMA M, Hamano T, Abe M, Masakane I, et al
    Encapsulating Peritoneal Sclerosis and Mortality Related to Infection in Patients on Combination Once-Weekly Hemodialysis with Peritoneal Dialysis.
    Am J Nephrol. 2021 Apr 23:1-6. doi: 10.1159/000515150.
    PubMed     Abstract available


  53. TANTISATTAMO E, Murray V, Obi Y, Park C, et al
    Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.
    Am J Nephrol. 2021 Apr 23:1-14. doi: 10.1159/000513855.
    PubMed     Abstract available


  54. WEI KY, Liao CY, Chung CH, Lin FH, et al
    Carbon Monoxide Poisoning and Chronic Kidney Disease Risk: A Nationwide, Population-Based Study.
    Am J Nephrol. 2021 Apr 22:1-12. doi: 10.1159/000515383.
    PubMed     Abstract available


  55. ALI H, Mohamed MM, Sharma A, Fulop T, et al
    Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2021 Apr 22:1-13. doi: 10.1159/000514454.
    PubMed     Abstract available


  56. PELLA E, Boutou A, Theodorakopoulou MP, Sarafidis P, et al
    Assessment of Exercise Intolerance in Patients with Pre-Dialysis CKD with Cardiopulmonary Function Testing: Translation to Everyday Practice.
    Am J Nephrol. 2021 Apr 21:1-15. doi: 10.1159/000515384.
    PubMed     Abstract available


  57. NAVARRETE JE, Tong DC, Cobb J, Rahbari-Oskoui FF, et al
    Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.
    Am J Nephrol. 2021 Apr 7:1-9. doi: 10.1159/000514752.
    PubMed     Abstract available


    March 2021
  58. FENG Y, Jones MR, Chu NM, Segev DL, et al
    Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis.
    Am J Nephrol. 2021 Mar 31:1-11. doi: 10.1159/000514233.
    PubMed     Abstract available


  59. MOROMIZATO T, Kohagura K, Tokuyama K, Shiohira Y, et al
    Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis.
    Am J Nephrol. 2021 Mar 23:1-11. doi: 10.1159/000513951.
    PubMed     Abstract available


  60. THURLOW JS, Joshi M, Yan G, Norris KC, et al
    Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
    Am J Nephrol. 2021 Mar 22:1-10. doi: 10.1159/000514550.
    PubMed     Abstract available


  61. CHO ME, Sweeney C, Fino N, Greene T, et al
    Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
    Am J Nephrol. 2021 Mar 18:1-11. doi: 10.1159/000514302.
    PubMed     Abstract available


  62. KIM AJ, Ro H, Kim H, Chang JH, et al
    Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
    Am J Nephrol. 2021 Mar 16:1-12. doi: 10.1159/000513663.
    PubMed     Abstract available


    February 2021
  63. PAI AY, Wenziger C, Streja E, Argueta DA, et al
    Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.
    Am J Nephrol. 2021 Feb 18:1-10. doi: 10.1159/000513381.
    PubMed     Abstract available


  64. JIANG J, Zhang Y, Chen J, Yang X, et al
    Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.
    Am J Nephrol. 2021 Feb 17:1-9. doi: 10.1159/000512385.
    PubMed     Abstract available


  65. NANGAKU M, Hamano T, Akizawa T, Tsubakihara Y, et al
    Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
    Am J Nephrol. 2021 Feb 9:1-10. doi: 10.1159/000513103.
    PubMed     Abstract available


  66. SANAI T, Okamura K, Onoue T, Ono T, et al
    Hemodilution Impacts Assessment of Thyroid Status before and after Hemodialysis in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2021;51:988-994.
    PubMed     Abstract available


    January 2021
  67. OLANIRAN KO, Eneanya ND, Zhao SH, Ofsthun NJ, et al
    Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis.
    Am J Nephrol. 2021 Jan 22:1-9. doi: 10.1159/000513012.
    PubMed     Abstract available


  68. PARK HC, Kwon YE, Choi HY, Oh HJ, et al
    Health Insurance Status Is Related to Risk of Mortality and Hospitalization in Korean Maintenance Hemodialysis Patients: A Longitudinal Cohort Study.
    Am J Nephrol. 2021 Jan 13:1-7. doi: 10.1159/000512855.
    PubMed     Abstract available


  69. RAJKUMAR T, Wong J, Harvey M, Weidersehn L, et al
    Comparison of Sampling Methods for International Normalized Ratio Monitoring in Haemodialysis Patients (INRHaemo Study).
    Am J Nephrol. 2021;52:17-25.
    PubMed     Abstract available


  70. SY J, Hsiung JT, Edgett D, Kalantar-Zadeh K, et al
    Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort.
    Am J Nephrol. 2021;52:199-208.
    PubMed     Abstract available


  71. SHESHADRI A, Kittiskulnam P, Delgado C, Sudore RL, et al
    Association of Cognitive Function Screening Results with Adherence and Performance in a Pedometer-Based Intervention.
    Am J Nephrol. 2021;52:420-428.
    PubMed     Abstract available


    October 2020
  72. GOLIGORSKY MS
    NET Formation in Dialysis: A Valuable, albeit Mysterious and Enticing Predictor of Mortality.
    Am J Nephrol. 2020 Oct 26:1-3. doi: 10.1159/000510772.
    PubMed    


  73. EINBINDER Y, Shnaider A, Ghanayem K, Basok A, et al
    Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality.
    Am J Nephrol. 2020 Oct 26:1-9. doi: 10.1159/000510771.
    PubMed     Abstract available


  74. YANG Y, Qin X, Li Y, Yang S, et al
    Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
    Am J Nephrol. 2020 Oct 16:1-10. doi: 10.1159/000509258.
    PubMed     Abstract available


    September 2020
  75. MACHHI R, Mandelbrot DA, Al-Qaoud T, Astor BC, et al
    Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell Carcinoma.
    Am J Nephrol. 2020 Sep 30:1-9. doi: 10.1159/000510616.
    PubMed     Abstract available


  76. DANESE MD, Lubeck D, Belozeroff V, Lin TC, et al
    Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
    Am J Nephrol. 2020 Sep 23:1-8. doi: 10.1159/000510360.
    PubMed     Abstract available


    July 2020
  77. AZIZ F, Ramadorai A, Parajuli S, Garg N, et al
    Obesity: An Independent Predictor of Morbidity and Graft Loss after Kidney Transplantation.
    Am J Nephrol. 2020 Jul 28:1-9. doi: 10.1159/000509105.
    PubMed     Abstract available


  78. HETZ P, Pirklbauer M, Muller S, Posch L, et al
    Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation.
    Am J Nephrol. 2020 Jul 13:1-9. doi: 10.1159/000508957.
    PubMed     Abstract available


    June 2020
  79. LYU B, Hansen KE, Jorgenson MR, Astor BC, et al
    Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
    Am J Nephrol. 2020 Jun 2:1-9. doi: 10.1159/000507470.
    PubMed     Abstract available


    April 2020
  80. CHU C, Hasan AA, Gaballa MMS, Zeng S, et al
    Endostatin Is an Independent Risk Factor of Graft Loss after Kidney Transplant.
    Am J Nephrol. 2020;51:373-380.
    PubMed     Abstract available


    March 2020
  81. RODAS LM, Ruiz-Ortiz E, Garcia-Herrera A, Pereira A, et al
    IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B Mismatch.
    Am J Nephrol. 2020 Mar 18:1-9. doi: 10.1159/000506853.
    PubMed     Abstract available


    January 2020
  82. SAEED F, Adams H, Epstein RM
    Matters of Life and Death: Why Do Older Patients Choose Conservative Management?
    Am J Nephrol. 2020;51:35-42.
    PubMed     Abstract available


    October 2019
  83. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
    Am J Nephrol. 2019 Oct 25:1-12. doi: 10.1159/000503713.
    PubMed     Abstract available


  84. FIRTH C, Kaur T, Chakkera H, Zhang N, et al
    Cardiac Troponin T and Right Ventricular Systolic Pressure Predict Cardiovascular and Mortality Risk in Kidney Transplant Candidates.
    Am J Nephrol. 2019 Oct 22:1-10. doi: 10.1159/000503807.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: